Lamm Robert 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Feb 19, 2009
Insider Transaction Report
Form 4
Lamm Robert
SVP, Quality & Reg. Affairs
Transactions
- Sale
Common Stock, $.01 par value per share
2009-02-17$5.71/sh−1,548$8,840→ 49,186 total
Footnotes (1)
- [F1]These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934, to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 15, 2007.